Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최윤희 | * |
dc.contributor.author | 김건 | * |
dc.contributor.author | 이재희 | * |
dc.date.accessioned | 2019-12-03T16:30:11Z | - |
dc.date.available | 2019-12-03T16:30:11Z | - |
dc.date.issued | 2019 | * |
dc.identifier.issn | 1334-5605 | * |
dc.identifier.other | OAK-26093 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/252252 | - |
dc.description.abstract | Background: Synthetic cannabinoids are recreational street drugs with many known adverse effects. Case presentation: Here we present the case of an atypical cerebral infarction in a patient with a suspected ingestion of synthetic cannabinoids. Conclusion: Although synthetic cannabinoids use is not conventionally associated with stroke, some case reports describe cerebral infarction and myocardial infarction with significant synthetic cannabinoids intake. Emergency physicians should know the association of synthetic cannabinoids with seizures, myocardial infarction, and now possibly ischemic stroke. | * |
dc.language | English | * |
dc.publisher | PHARMAMED MADO LTD | * |
dc.subject | stroke | * |
dc.subject | cannabinoids | * |
dc.subject | synthetic cannabinoids | * |
dc.subject | case report | * |
dc.title | Atypical Cerebral Infarction in a Patient Suspected Ingestion of Synthetic Cannabinoids | * |
dc.type | Article | * |
dc.relation.issue | 2 | * |
dc.relation.volume | 15 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 67 | * |
dc.relation.lastpage | 69 | * |
dc.relation.journaltitle | SIGNA VITAE | * |
dc.identifier.doi | 10.22514/SV152.092019.11 | * |
dc.identifier.wosid | WOS:000496918200011 | * |
dc.author.google | Lee, Jae Hee | * |
dc.author.google | Kim, Keon | * |
dc.author.google | Lee, Dong Hoon | * |
dc.author.google | Choi, Yoon Hee | * |
dc.contributor.scopusid | 최윤희(57190749692;58492359100) | * |
dc.contributor.scopusid | 김건(57199091586) | * |
dc.date.modifydate | 20240318142018 | * |